Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-03-11
2008-03-11
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
11467123
ABSTRACT:
Disclosed is a method of using a compound as an inhibitor for β-secretase, wherein the compound is capable of binding to the site within the β-secretase recognition and/or cleavage site on amyloid precursor protein to specifically inhibit the β-secretase's activity to cleave amyloid precursor protein with maintaining its activities to other substrates. Further, the present invention relates to inhibitors of amyloid precursor protein (APP) processing which bind to the site within the β-secretase or γ-secretase cleavage and/or recognition site on amyloid precursor protein.
REFERENCES:
patent: 6329163 (2001-12-01), Anderson et al.
patent: 6713276 (2004-03-01), Cordell et al.
patent: WO 98/07850 (1997-08-01), None
patent: WO 02/36614 (2001-11-01), None
Yamada, “Cerebral amyloid angiopathy: An overview”, Neuropathology (2000), 20(1): 8-22.
Citron et al., “Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production”, Nature (1992), 360: 672-674.
Schenk et al., “Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse”, Nature (1999), 400(6740): 173-177.
Lewis et al., “Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP”, Science (2001), 293(5534): 1487-1491.
Calhoun et al., “Neuron loss in APP transgenic mice”, Nature (1998), 395(6704): 755-756.
Vassar et al., “A-Beta-Generating Enzymes: Recent Advances in Beta- and Gamma-Secretase Research”, Neuron (2000), 27(3): 419-422.
Yankner, “Mechanisms of Neuronal Degeneration in Alzheimer's Disease”, Neuron (1996), 16(5): 921-932.
Haass et al., “Amyloid beta-peptide is produced by cultured cells during normal metabolism”, Nature (1992), 359: 322-325.
Seubert et al., Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide, Nature (1993), 361: 260-263.
Sisodia, “Beta-Amyloid precursor protein cleavage by a membrane-bound protease”, Proc. Natl. Acad. Sci. USA (1992), 89: 6075-6079.
Forman et al., “Differential Effects of the Swedish Mutant Amyloid Precursor Protein on Beta-Amyloid Accumulation and Secretion in Neurons and Nonneuronal Cells”, J. Biol. Chem. (1997), 272: 32247-32253.
Chyung et al., “Novel Beta-Secretase Cleavage of Beta-Amyloid Precursor Protein in the Endoplasmic Reticulum/Intermediate Compartment of NT2N Cells”, J. Cell. Bio. (1997), 138: 671-680.
Goate et al., “Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease”, Nature (1991), 349: 704-706.
Giaccone et al., “Down patients: extracellular preamyloid deposits precede neuritic degeneration and senile plaques”, Neuroscience Letters (1989), 97: 232-238.
Jarrett et al., “The Carboxy Terminus of the Beta Amyloid Protein Is Critical for the Seeding of Amyloid Formation: Implications for the Pathogenesis of Alzheimer's Disease”, Biochemistry (1993), 32: 4693-7.
Seubert et al., “Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids”, Nature (1992), 359: 325-327.
Thomas et al., “Beta-Amyloid-mediated vasoactivity and vascular endothelial damage”, Nature (1996), 380 (6570): 168-171.
Sommer, “Alzheimer's disease and the amyloid cascade hypothesis: ten years on”, Curr. Opin. Pharmacol. (2002), 2(1): 87-92.
Marti et al., “Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors”, Proc. Natl. Acad. Sci. USA (1998), 95(26): 15809-15814.
Hardy et al., “Alzheimer's Disease: The Amyloid Cascade Hypothesis”, Science (1992), 256(5054): 184-185.
Hsiao et al., “Correlative Memory Deficits, A-BetaElevation, and Amyloid Plaques in Transgenic Mice”, Science (1996), 274(5284): 99-102.
Sisodia et al., “Evidence That Beta-Amyloid Protein in Alzheimer's Disease Is Not Derived by Normal Processing”, Science (1990), 248: 492-495.
Iwatsubo et al., “Visualization of A-Beta42(43) and A-Beta40 in Senile Plaques with End-Specific A-Beta Monoclonals: Evidence That an Initially Deposited Species Is A-Beta42(43)”, Neuron (1993), 13: 45-53.
Jarrett et al., “Seeding “One-Dimensional Crystallization” of Amyloid: A Pathogenic Mechanism in Alzheimer's Disease and Scrapie?”, Cell (1993), 73: 1055-1058.
Gho et al., “Anti-angiogenin Activity of the Peptides Complementary to the Receptor-binding Site of Angiogenin”, The Journal of Biological Chemistry (1997), 272(39): 24294-24299.
Grüninger-Leitch et al., “Substrate and Inhibitor Profile of BACE (B-Secretase) and Comparison with Other Mammalian Aspartic Proteases”, The Journal of Biological Chemistry (2002), 277(7): 4687-4693.
Murphy et al., “y-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid B Peptides of Varying Length”, The Journal of Biological Chemistry (1999), 274(17): 11914-11923.
Beher et al., “Generation of C-terminally truncated amyloid-B peptides is dependent on y-secretase activity”, Journal of Neurochemistry (2002), 82: 563-575.
Shearman et al., “L-685,458 as Aspartyl Protease Transition State Mimic, Is a Potent Inhibitor of Amyloid B-Protein Precursor y-Secretase Activity”, Biochemistry (2000), 39: 8698-8704.
Chae Chi-Bom
Gho Yong Song
Jeon Sanghee
Na Chan Hyun
Audet Maury
JHK Law
Kim Joseph Hyosuk
Posco
Postech Foundation
LandOfFree
Inhibitors of amyloid precursor protein processing does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of amyloid precursor protein processing, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of amyloid precursor protein processing will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3942148